Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.220
+0.010 (0.83%)
Nov 7, 2024, 4:00 PM EST - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Apyx Medical stock has a target of 5.00, which predicts an increase of 309.84% from the current stock price of 1.22.
Analyst Consensus: Hold
* Price targets were last updated on Nov 10, 2023.
Analyst Ratings
The average analyst rating for Apyx Medical stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +309.84% | Nov 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +268.85% | Aug 11, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +555.74% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
51.78M
from 52.35M
Decreased by -1.08%
Revenue Next Year
55.13M
from 51.78M
Increased by 6.46%
EPS This Year
-0.72
from -0.54
EPS Next Year
-0.68
from -0.72
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 53.6M | 57.2M | 65.1M | ||
| Avg | 51.8M | 55.1M | 62.3M | ||
| Low | 49.6M | 52.4M | 59.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.4% | 10.5% | 18.1% | ||
| Avg | -1.1% | 6.5% | 13.1% | ||
| Low | -5.3% | 1.3% | 7.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.72 | -0.58 | -0.54 | ||
| Avg | -0.72 | -0.68 | -0.53 | ||
| Low | -0.74 | -0.74 | -0.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.